Literature DB >> 25774690

Correction: Evaluating the cost-effectiveness of lifestyle modification versus metformin therapy for the prevention of diabetes in Singapore.

.   

Abstract

Entities:  

Year:  2015        PMID： 25774690      PMCID： PMC4361762          DOI： 10.1371/journal.pone.0120831

Source DB:  PubMed          Journal:  PLoS One        ISSN： 1932-6203            Impact factor:   3.240


× No keyword cloud information.
In Table 6, the value of ICER of metformin intervention (Health system) at QALY = 2.09 should be 2,489. Please see the corrected Table 6 here.
Table 6

One-way sensitivity analysis of metformin intervention’s effectiveness

ICER of metformin intervention (Health system)ICER of metformin intervention (Societal)
Cost of metformin intervention 8,33126,728
QALY
1.79DominatedDominated
1.89DominatedDominated
1.9921,0656,367
2.092,489752
2.191,323400

QALY: quality adjusted life years; ICER: incremental cost-effectiveness ratio (in 2012US$ per QALY)

QALY: quality adjusted life years; ICER: incremental cost-effectiveness ratio (in 2012US$ per QALY)
  1 in total

1.  Evaluating the cost-effectiveness of lifestyle modification versus metformin therapy for the prevention of diabetes in Singapore.

Authors:  May Ee Png; Joanne Su-Yin Yoong
Journal:  PLoS One       Date:  2014-09-09       Impact factor: 3.240
  1 in total
  1 in total

Review 1.  Review of Metformin Use for Type 2 Diabetes Prevention.

Authors:  Tannaz Moin; Julie A Schmittdiel; James H Flory; Jessica Yeh; Andrew J Karter; Lydia E Kruge; Dean Schillinger; Carol M Mangione; William H Herman; Elizabeth A Walker
Journal:  Am J Prev Med       Date:  2018-08-17       Impact factor: 6.604
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.